These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities]. Porschen R; Bermann A Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798 [No Abstract] [Full Text] [Related]
4. Adjuvant chemotherapy for colorectal cancer. Kerr DJ; Gray R Br J Hosp Med; 1996 Mar 6-19; 55(5):259-62. PubMed ID: 8777517 [No Abstract] [Full Text] [Related]
5. [Therapeutic strategies in colorectal cancer]. Flieger D; Keller R; Fischbach W Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825 [No Abstract] [Full Text] [Related]
6. Adjuvant cytotoxic chemotherapy for colorectal cancer: the present position. Taylor I Aust N Z J Surg; 1988 Sep; 58(9):687-91. PubMed ID: 2977942 [No Abstract] [Full Text] [Related]
7. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer. Malik Z; Eng C Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584 [No Abstract] [Full Text] [Related]
11. Liver metastases of colorectal cancer: medical treatments. Pasetto LM; Rossi E; Monfardini S Anticancer Res; 2003; 23(5b):4245-56. PubMed ID: 14666634 [TBL] [Abstract][Full Text] [Related]
12. In defense of hepatic arterial infusion for hepatic metastases of colorectal cancer. Kemeny N J Natl Compr Canc Netw; 2010 May; 8(5):507-9. PubMed ID: 20495081 [No Abstract] [Full Text] [Related]
13. Cancers of the large bowel and hepatobiliary tract. Sun W; Haller D Cancer Chemother Biol Response Modif; 2003; 21():509-34. PubMed ID: 15338761 [No Abstract] [Full Text] [Related]
14. Second line therapies move to the forefront in colorectal cancer. Miller M J Natl Cancer Inst; 1999 Jun; 91(12):998-1000. PubMed ID: 10379961 [No Abstract] [Full Text] [Related]
15. [Hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: a phase II trial]. Strobel O; Büchler MW Chirurg; 2014 Jul; 85(7):641. PubMed ID: 24934110 [No Abstract] [Full Text] [Related]
16. [Locoregional therapy in hepatic metastases of colorectal cancer]. Pancera G; Secondino S; Mastore M; Garassino MC Tumori; 2001; 87(1 Suppl 1):S70-2. PubMed ID: 11300033 [No Abstract] [Full Text] [Related]
18. Does chemotherapy given directly to the liver improve survival in patients with hepatic metastasis? Kerr DJ Nat Clin Pract Oncol; 2006 Sep; 3(9):480-1. PubMed ID: 16955085 [No Abstract] [Full Text] [Related]
19. Treatment options for metastatic colorectal cancer in patients with liver dysfunction due to malignancy. Faugeras L; Dili A; Druez A; Krug B; Decoster C; D'Hondt L Crit Rev Oncol Hematol; 2017 Jul; 115():59-66. PubMed ID: 28602170 [TBL] [Abstract][Full Text] [Related]
20. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference? Graziano F; Cascinu S J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535 [No Abstract] [Full Text] [Related] [Next] [New Search]